Clinical Biologics Pipeline

Trials for Market Approval

Celecoxib WBA

SPRINT-TB (National University of Singapore)

Hsp65 DNA

TGF-B inhib +Cox 2 inhibitor

CC-11050, Auranofin, Everolimus, Vitamin D3 plus Rifabutin-modified TB Therapy

The Aurum Institute NPC, Medicines Development for Global Health

Immunoxel